
    
      This post market clinical follow-up investigation is designed as an open, non-controlled,
      multi- centre, clinical investigation.

      A total of approximately 25 subjects from among 4-6 clinical investigative sites will be
      evaluated providing they fulfill all the inclusion criteria and none of the exclusion
      criteria. A signed and dated informed consent/assent will be obtained for all subjects.

      Subjects to be included will present with a thermal burn injury that will require skin
      grafting and result in a donor site. Overall percent Total Body Surface Area (%TBSA) burned
      will not exceed 30%.

      The subjects will be consecutively allocated to a subject code providing they fulfill all
      inclusion criteria and none of the exclusion criteria and have signed a written consent.

      The subjects were participating in the study for 14 days postop.
    
  